SLS

SELLAS Life Sciences Group, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-7.5M
ExitQ1 2026
$7.5M
--
$8.58
Paul Tudor Jones IITudor Investment
$1.3M314.4k shares
TrimQ1 2026
$3.6M
$4.23
$8.58
Jefferies GroupInvestor
$-76.2K
ExitQ1 2026
$76k
--
$8.58
Ken GriffinCitadel Advisors
$7.5M2M shares
AddQ4 2025
$6.2M
$3.77
$8.58
Jim SimonsRenaissance Technologies
$-469.8K
ExitQ4 2025
$470k
--
$8.58
Ken GriffinCitadel Advisors
$573.9K
AddQ2 2025
$574k
--
$8.58

News

benzinga.comSELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?benzinga.comMay 20globenewswire.comSELLAS Life Sciences to Participate in Upcoming Investor Conferencesglobenewswire.comMay 14benzinga.comSELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progressesbenzinga.comMay 13globenewswire.comSELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Updateglobenewswire.comMay 12seekingalpha.comSellas Life Sciences: 'Hold' As Phase 3 AML Study Progresses To Key Eventseekingalpha.comApr 23